# Buzz Radar Limited - Strategic Business Context
# Source: AI CFO Knowledge Base (November 2025)
# For AI CFO system contextual understanding

company:
  name: "Buzz Radar Limited"
  registered: "UK"
  founded: 2012
  classification: "Bootstrapped, profitable, no external capital"

# CRITICAL CONTEXT: Business Model Transition
business_model:
  current_state: "100% services-led"
  description: "Plug-in insights department - deeply integrated with pharma marketing organisations"
  future_state: "Platform-led with human validation layer"
  
  transition_timeline:
    end_2026: "75% platform, 25% services"
    mid_2027: "90%+ platform revenue"
  
  why_transition:
    - "Services scales linearly with headcount"
    - "Platform scales exponentially"
    - "SaaS valuations: 8-10x revenue"
    - "Services valuations: 3-6x EBITDA"

# Current Financial Position (2025)
financials:
  annual_revenue: 1300000
  gross_margin: 94  # Percent - exceptional for services
  net_margin: 11  # Percent
  net_profit: 148000
  yoy_growth: 109  # More than doubled from £622k in 2024
  prior_year_revenue: 622000
  cash_position: "Positive - self-funding"
  external_capital: "None required"

# Services Business Model
services_model:
  description: "Outsourced intelligence function embedded within client organisations"
  characteristics:
    - "High client intimacy"
    - "Strong retention"
    - "Labour-intensive"
    - "Scales linearly with headcount"
  
  offerings:
    - name: "Digital Listening Programs"
      description: "Ongoing monitoring and analysis of social conversations around brands, diseases, competitors"
    - name: "Digital Opinion Leader (DOL) Tracking"
      description: "Identification and analysis of HCPs with digital influence"
    - name: "Competitive Intelligence"
      description: "Monitoring competitor activities, launches, messaging strategies"
    - name: "Content Performance Analysis"
      description: "Evaluating what content resonates with target audiences"
    - name: "Strategic Reporting"
      description: "Regular insight delivery to marketing and medical affairs teams"

# BRIANN Product
briann:
  full_name: "Buzz Radar Insight Analyst Neural Network"
  origin: "Internal competitive advantage - made services team dramatically more efficient"
  status: "Transitioning from internal tool to productised platform"
  
  internal_capabilities:
    - capability: "Insight Generation"
      description: "Rapidly analyse millions of healthcare conversations for trends and patterns"
    - capability: "DOL Identification"
      description: "AI-powered mapping of digital opinion leaders by therapeutic area and geography"
    - capability: "Pre-Compliance Checking"
      description: "Screen content against ABPI, EFPIA, PAAB, MHRA, PhRMA codes"
    - capability: "Content Strategy"
      description: "Analyse what content performs and why, with AI recommendations"
    - capability: "Speed Multiplier"
      description: "90% faster insight delivery than traditional methods"
  
  modules:
    - name: "Insights Analyst"
      function: "Explains trends, spikes, patterns in social conversations"
    - name: "Influencer Mapper"
      function: "Identifies and ranks DOLs for therapeutic areas and geographies"
    - name: "Compliance Engine"
      function: "Pre-screens content with traffic-light recommendations"
    - name: "Data-Driven Strategist"
      function: "Analyses content performance with recommendations"
    - name: "Pharmacovigilance Monitor"
      function: "Scans for ADR mentions across social media"
      status: "In development"
  
  architecture:
    model: "Human-in-Loop"
    principle: "AI does heavy lifting; humans provide validation for compliance-sensitive outputs"
    why_matters: "Pure automation unacceptable in pharma due to regulatory and legal liability"
    
    deployment_options:
      - type: "Cloud SaaS"
        for: "Smaller pharma comfortable with cloud"
      - type: "Client-Side Deployment"
        for: "Security-sensitive enterprises using their own LLM infrastructure"
        examples: ["Azure OpenAI", "AWS Bedrock", "Private models"]
      - type: "Model Neutrality"
        description: "Orchestrates multiple LLMs (GPT-4, Claude, Gemini)"
    
    competitive_advantage: "Most pharma IT blocks ChatGPT/Claude. BRIANN operates within client firewalls using their model instances - solves access problem, not just capability problem"

# First Product Pilot
ferring_pilot:
  client: "Ferring Pharmaceuticals"
  status: "First external BRIANN deployment"
  start_date: "December 2025"
  duration: "90-day evaluation"
  pricing: 30000
  pricing_rationale: "Minimise procurement friction"
  conversion_target: "£100-250K production contract"
  success_criteria: "To be defined within first 14 days"
  strategic_significance: "Validates BRIANN can be sold as product, not just embedded in services. Proves land-and-expand model works."

# 2026 Pilot Pipeline
pilot_pipeline_2026:
  standardised_price: 30000
  prospects:
    - company: "GSK"
      therapeutic_focus: "Various"
    - company: "Merck"
      therapeutic_focus: "Various"
    - company: "UCB"
      therapeutic_focus: "Various"
    - company: "Chugai"
      therapeutic_focus: "Various"
    - company: "CSL"
      therapeutic_focus: "Various"
    - company: "BioMarin"
      therapeutic_focus: "Various"
  
  economics:
    pilot_margin: "Potentially negative - treat as CAC"
    production_margin_target: "70-85%"
    conversion_target: "60-70%"

# Cost Structure
cost_structure:
  current_model: "Services - 94% gross margin"
  
  platform_costs:
    data_apis:
      x_twitter_enterprise:
        cost: 42000
        frequency: "monthly"
        currency: "USD"
        notes: "Material fixed cost - ~$504k annually"
      reddit:
        cost: 0.24
        unit: "per 1,000 calls"
        notes: "Historical analyses can generate unexpected costs"
    
    llm_inference:
      type: "Variable - scales with usage"
      note: "Monitor discriminative vs generative ratio - discriminative is cheaper"
    
    human_validation:
      type: "Labour cost"
      note: "Must be systematised and made efficient, NOT eliminated - it's a differentiator"
  
  key_metrics_to_track:
    - "Token Consumption Rate"
    - "API Efficiency Ratio (revenue per £1 API spend)"
    - "Cost per Insight"
    - "Data Source Dependency Ratio"

# Exit Thesis
exit_strategy:
  target_year: 2030
  valuation_target:
    low: 35000000
    high: 50000000
  
  requirements:
    revenue: "£3.5-4.5M by 2029"
    revenue_mix: "90%+ platform by 2027"
    client_base: "15-20 active clients"
    concentration: "No single client >30%"
    profitability: "Maintain 10-15% net margin throughout transition"

# Strategic Milestones
milestones:
  q1_2026:
    - "Ferring pilot completion"
    - "Conversion decision"
  q2_2026:
    - "3-4 additional BRIANN pilots activated"
  q3_2026:
    - "First production BRIANN contracts signed"
  q4_2026:
    - "Revenue mix: 25%+ platform, 75% services"
    - "Transition underway"
